2018-2023 Global Human Rabies Immunoglobulin (IM) Consumption Market Report

September 2018 | 167 pages | ID: 276519A38E6EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Human Rabies Immunoglobulin (IM) market for 2018-2023.

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.

Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization.

In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)
Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure. It is given after the wound is cleaned with soap and water or providone-iodine and is followed by a course of rabies vaccine.
The use of rabies immunoglobulin in the form of blood serum dates from 1891. Use become common within medicine in the 1950s. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.
The classification according to the material of Human Rabies Immunoglobulin (IM) includes ERIG, HRIG, and the proportion of HRIG in 2017is about 86.7%, and the proportion is in increasing trend from 2013 to 2017.
Over the next five years, LPI(LP Information) projects that Human Rabies Immunoglobulin (IM) will register a 7.3% CAGR in terms of revenue, reach US$ 440 million by 2023, from US$ 290 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Rabies Immunoglobulin (IM) market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• ERIG
• HRIG

Segmentation by application:

• Category II Exposure
• Category III Exposure

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• CSL Behring
• Grifols 
• Sanofi
• Sichuan Yuanda Shuyang
• CNBG
• Kamada
• CBPO
• Shuanglin Bio
• Weiguang Bio
• Shanghai RAAS
• Bharat Serum
• VINS

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Human Rabies Immunoglobulin (IM) consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Human Rabies Immunoglobulin (IM) market by identifying its various subsegments.
• Focuses on the key global Human Rabies Immunoglobulin (IM) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Human Rabies Immunoglobulin (IM) with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Human Rabies Immunoglobulin (IM) submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Human Rabies Immunoglobulin (IM) Consumption 2013-2023
  2.1.2 Human Rabies Immunoglobulin (IM) Consumption CAGR by Region
2.2 Human Rabies Immunoglobulin (IM) Segment by Type
  2.2.1 ERIG
  2.2.2 HRIG
2.3 Human Rabies Immunoglobulin (IM) Consumption by Type
  2.3.1 Global Human Rabies Immunoglobulin (IM) Consumption Market Share by Type (2013-2018)
  2.3.2 Global Human Rabies Immunoglobulin (IM) Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Human Rabies Immunoglobulin (IM) Sale Price by Type (2013-2018)
2.4 Human Rabies Immunoglobulin (IM) Segment by Application
  2.4.1 Category II Exposure
  2.4.2 Category III Exposure
2.5 Human Rabies Immunoglobulin (IM) Consumption by Application
  2.5.1 Global Human Rabies Immunoglobulin (IM) Consumption Market Share by Application (2013-2018)
  2.5.2 Global Human Rabies Immunoglobulin (IM) Value and Market Share by Application (2013-2018)
  2.5.3 Global Human Rabies Immunoglobulin (IM) Sale Price by Application (2013-2018)

3 GLOBAL HUMAN RABIES IMMUNOGLOBULIN (IM) BY PLAYERS

3.1 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Players
  3.1.1 Global Human Rabies Immunoglobulin (IM) Sales by Players (2016-2018)
  3.1.2 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Players (2016-2018)
3.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Players
  3.2.1 Global Human Rabies Immunoglobulin (IM) Revenue by Players (2016-2018)
  3.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Players (2016-2018)
3.3 Global Human Rabies Immunoglobulin (IM) Sale Price by Players
3.4 Global Human Rabies Immunoglobulin (IM) Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Human Rabies Immunoglobulin (IM) Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Human Rabies Immunoglobulin (IM) Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 HUMAN RABIES IMMUNOGLOBULIN (IM) BY REGIONS

4.1 Human Rabies Immunoglobulin (IM) by Regions
  4.1.1 Global Human Rabies Immunoglobulin (IM) Consumption by Regions
  4.1.2 Global Human Rabies Immunoglobulin (IM) Value by Regions
4.2 Americas Human Rabies Immunoglobulin (IM) Consumption Growth
4.3 APAC Human Rabies Immunoglobulin (IM) Consumption Growth
4.4 Europe Human Rabies Immunoglobulin (IM) Consumption Growth
4.5 Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption Growth

5 AMERICAS

5.1 Americas Human Rabies Immunoglobulin (IM) Consumption by Countries
  5.1.1 Americas Human Rabies Immunoglobulin (IM) Consumption by Countries (2013-2018)
  5.1.2 Americas Human Rabies Immunoglobulin (IM) Value by Countries (2013-2018)
5.2 Americas Human Rabies Immunoglobulin (IM) Consumption by Type
5.3 Americas Human Rabies Immunoglobulin (IM) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Human Rabies Immunoglobulin (IM) Consumption by Countries
  6.1.1 APAC Human Rabies Immunoglobulin (IM) Consumption by Countries (2013-2018)
  6.1.2 APAC Human Rabies Immunoglobulin (IM) Value by Countries (2013-2018)
6.2 APAC Human Rabies Immunoglobulin (IM) Consumption by Type
6.3 APAC Human Rabies Immunoglobulin (IM) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Human Rabies Immunoglobulin (IM) by Countries
  7.1.1 Europe Human Rabies Immunoglobulin (IM) Consumption by Countries (2013-2018)
  7.1.2 Europe Human Rabies Immunoglobulin (IM) Value by Countries (2013-2018)
7.2 Europe Human Rabies Immunoglobulin (IM) Consumption by Type
7.3 Europe Human Rabies Immunoglobulin (IM) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Human Rabies Immunoglobulin (IM) by Countries
  8.1.1 Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Human Rabies Immunoglobulin (IM) Value by Countries (2013-2018)
8.2 Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption by Type
8.3 Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Human Rabies Immunoglobulin (IM) Distributors
10.3 Human Rabies Immunoglobulin (IM) Customer

11 GLOBAL HUMAN RABIES IMMUNOGLOBULIN (IM) MARKET FORECAST

11.1 Global Human Rabies Immunoglobulin (IM) Consumption Forecast (2018-2023)
11.2 Global Human Rabies Immunoglobulin (IM) Forecast by Regions
  11.2.1 Global Human Rabies Immunoglobulin (IM) Forecast by Regions (2018-2023)
  11.2.2 Global Human Rabies Immunoglobulin (IM) Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Human Rabies Immunoglobulin (IM) Forecast by Type
11.8 Global Human Rabies Immunoglobulin (IM) Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 CSL Behring
  12.1.1 Company Details
  12.1.2 Human Rabies Immunoglobulin (IM) Product Offered
  12.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 CSL Behring News
12.2 Grifols
  12.2.1 Company Details
  12.2.2 Human Rabies Immunoglobulin (IM) Product Offered
  12.2.3 Grifols Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Grifols News
12.3 Sanofi
  12.3.1 Company Details
  12.3.2 Human Rabies Immunoglobulin (IM) Product Offered
  12.3.3 Sanofi Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Sanofi News
12.4 Sichuan Yuanda Shuyang
  12.4.1 Company Details
  12.4.2 Human Rabies Immunoglobulin (IM) Product Offered
  12.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Sichuan Yuanda Shuyang News
12.5 CNBG
  12.5.1 Company Details
  12.5.2 Human Rabies Immunoglobulin (IM) Product Offered
  12.5.3 CNBG Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 CNBG News
12.6 Kamada
  12.6.1 Company Details
  12.6.2 Human Rabies Immunoglobulin (IM) Product Offered
  12.6.3 Kamada Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Kamada News
12.7 CBPO
  12.7.1 Company Details
  12.7.2 Human Rabies Immunoglobulin (IM) Product Offered
  12.7.3 CBPO Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 CBPO News
12.8 Shuanglin Bio
  12.8.1 Company Details
  12.8.2 Human Rabies Immunoglobulin (IM) Product Offered
  12.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Shuanglin Bio News
12.9 Weiguang Bio
  12.9.1 Company Details
  12.9.2 Human Rabies Immunoglobulin (IM) Product Offered
  12.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Weiguang Bio News
12.10 Shanghai RAAS
  12.10.1 Company Details
  12.10.2 Human Rabies Immunoglobulin (IM) Product Offered
  12.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Shanghai RAAS News
12.11 Bharat Serum
12.12 VINS

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Human Rabies Immunoglobulin (IM)
Table Product Specifications of Human Rabies Immunoglobulin (IM)
Figure Human Rabies Immunoglobulin (IM) Report Years Considered
Figure Market Research Methodology
Figure Global Human Rabies Immunoglobulin (IM) Consumption Growth Rate 2013-2023 (K Units)
Figure Global Human Rabies Immunoglobulin (IM) Value Growth Rate 2013-2023 ($ Millions)
Table Human Rabies Immunoglobulin (IM) Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of ERIG
Table Major Players of ERIG
Figure Product Picture of HRIG
Table Major Players of HRIG
Table Global Consumption Sales by Type (2013-2018)
Table Global Human Rabies Immunoglobulin (IM) Consumption Market Share by Type (2013-2018)
Figure Global Human Rabies Immunoglobulin (IM) Consumption Market Share by Type (2013-2018)
Table Global Human Rabies Immunoglobulin (IM) Revenue by Type (2013-2018) ($ million)
Table Global Human Rabies Immunoglobulin (IM) Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Human Rabies Immunoglobulin (IM) Value Market Share by Type (2013-2018)
Table Global Human Rabies Immunoglobulin (IM) Sale Price by Type (2013-2018)
Figure Human Rabies Immunoglobulin (IM) Consumed in Category II Exposure
Figure Global Human Rabies Immunoglobulin (IM) Market: Category II Exposure (2013-2018) (K Units)
Figure Global Human Rabies Immunoglobulin (IM) Market: Category II Exposure (2013-2018) ($ Millions)
Figure Global Category II Exposure YoY Growth ($ Millions)
Figure Human Rabies Immunoglobulin (IM) Consumed in Category III Exposure
Figure Global Human Rabies Immunoglobulin (IM) Market: Category III Exposure (2013-2018) (K Units)
Figure Global Human Rabies Immunoglobulin (IM) Market: Category III Exposure (2013-2018) ($ Millions)
Figure Global Category III Exposure YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Human Rabies Immunoglobulin (IM) Consumption Market Share by Application (2013-2018)
Figure Global Human Rabies Immunoglobulin (IM) Consumption Market Share by Application (2013-2018)
Table Global Human Rabies Immunoglobulin (IM) Value by Application (2013-2018)
Table Global Human Rabies Immunoglobulin (IM) Value Market Share by Application (2013-2018)
Figure Global Human Rabies Immunoglobulin (IM) Value Market Share by Application (2013-2018)
Table Global Human Rabies Immunoglobulin (IM) Sale Price by Application (2013-2018)
Table Global Human Rabies Immunoglobulin (IM) Sales by Players (2016-2018) (K Units)
Table Global Human Rabies Immunoglobulin (IM) Sales Market Share by Players (2016-2018)
Figure Global Human Rabies Immunoglobulin (IM) Sales Market Share by Players in 2016
Figure Global Human Rabies Immunoglobulin (IM) Sales Market Share by Players in 2017
Table Global Human Rabies Immunoglobulin (IM) Revenue by Players (2016-2018) ($ Millions)
Table Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Players (2016-2018)
Figure Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Players in 2016
Figure Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Players in 2017
Table Global Human Rabies Immunoglobulin (IM) Sale Price by Players (2016-2018)
Figure Global Human Rabies Immunoglobulin (IM) Sale Price by Players in 2017
Table Global Human Rabies Immunoglobulin (IM) Manufacturing Base Distribution and Sales Area by Players
Table Players Human Rabies Immunoglobulin (IM) Products Offered
Table Human Rabies Immunoglobulin (IM) Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Human Rabies Immunoglobulin (IM) Consumption by Regions 2013-2018 (K Units)
Table Global Human Rabies Immunoglobulin (IM) Consumption Market Share by Regions 2013-2018
Figure Global Human Rabies Immunoglobulin (IM) Consumption Market Share by Regions 2013-2018
Table Global Human Rabies Immunoglobulin (IM) Value by Regions 2013-2018 ($ Millions)
Table Global Human Rabies Immunoglobulin (IM) Value Market Share by Regions 2013-2018
Figure Global Human Rabies Immunoglobulin (IM) Value Market Share by Regions 2013-2018
Figure Americas Human Rabies Immunoglobulin (IM) Consumption 2013-2018 (K Units)
Figure Americas Human Rabies Immunoglobulin (IM) Value 2013-2018 ($ Millions)
Figure APAC Human Rabies Immunoglobulin (IM) Consumption 2013-2018 (K Units)
Figure APAC Human Rabies Immunoglobulin (IM) Value 2013-2018 ($ Millions)
Figure Europe Human Rabies Immunoglobulin (IM) Consumption 2013-2018 (K Units)
Figure Europe Human Rabies Immunoglobulin (IM) Value 2013-2018 ($ Millions)
Figure Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption 2013-2018 (K Units)
Figure Middle East & Africa Human Rabies Immunoglobulin (IM) Value 2013-2018 ($ Millions)
Table Americas Human Rabies Immunoglobulin (IM) Consumption by Countries (2013-2018) (K Units)
Table Americas Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries (2013-2018)
Figure Americas Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries in 2017
Table Americas Human Rabies Immunoglobulin (IM) Value by Countries (2013-2018) ($ Millions)
Table Americas Human Rabies Immunoglobulin (IM) Value Market Share by Countries (2013-2018)
Figure Americas Human Rabies Immunoglobulin (IM) Value Market Share by Countries in 2017
Table Americas Human Rabies Immunoglobulin (IM) Consumption by Type (2013-2018) (K Units)
Table Americas Human Rabies Immunoglobulin (IM) Consumption Market Share by Type (2013-2018)
Figure Americas Human Rabies Immunoglobulin (IM) Consumption Market Share by Type in 2017
Table Americas Human Rabies Immunoglobulin (IM) Consumption by Application (2013-2018) (K Units)
Table Americas Human Rabies Immunoglobulin (IM) Consumption Market Share by Application (2013-2018)
Figure Americas Human Rabies Immunoglobulin (IM) Consumption Market Share by Application in 2017
Figure United States Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure United States Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure Canada Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Canada Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure Mexico Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Mexico Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Table APAC Human Rabies Immunoglobulin (IM) Consumption by Countries (2013-2018) (K Units)
Table APAC Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries (2013-2018)
Figure APAC Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries in 2017
Table APAC Human Rabies Immunoglobulin (IM) Value by Countries (2013-2018) ($ Millions)
Table APAC Human Rabies Immunoglobulin (IM) Value Market Share by Countries (2013-2018)
Figure APAC Human Rabies Immunoglobulin (IM) Value Market Share by Countries in 2017
Table APAC Human Rabies Immunoglobulin (IM) Consumption by Type (2013-2018) (K Units)
Table APAC Human Rabies Immunoglobulin (IM) Consumption Market Share by Type (2013-2018)
Figure APAC Human Rabies Immunoglobulin (IM) Consumption Market Share by Type in 2017
Table APAC Human Rabies Immunoglobulin (IM) Consumption by Application (2013-2018) (K Units)
Table APAC Human Rabies Immunoglobulin (IM) Consumption Market Share by Application (2013-2018)
Figure APAC Human Rabies Immunoglobulin (IM) Consumption Market Share by Application in 2017
Figure China Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure China Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure Japan Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Japan Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure Korea Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Korea Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure India Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure India Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure Australia Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Australia Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Table Europe Human Rabies Immunoglobulin (IM) Consumption by Countries (2013-2018) (K Units)
Table Europe Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries (2013-2018)
Figure Europe Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries in 2017
Table Europe Human Rabies Immunoglobulin (IM) Value by Countries (2013-2018) ($ Millions)
Table Europe Human Rabies Immunoglobulin (IM) Value Market Share by Countries (2013-2018)
Figure Europe Human Rabies Immunoglobulin (IM) Value Market Share by Countries in 2017
Table Europe Human Rabies Immunoglobulin (IM) Consumption by Type (2013-2018) (K Units)
Table Europe Human Rabies Immunoglobulin (IM) Consumption Market Share by Type (2013-2018)
Figure Europe Human Rabies Immunoglobulin (IM) Consumption Market Share by Type in 2017
Table Europe Human Rabies Immunoglobulin (IM) Consumption by Application (2013-2018) (K Units)
Table Europe Human Rabies Immunoglobulin (IM) Consumption Market Share by Application (2013-2018)
Figure Europe Human Rabies Immunoglobulin (IM) Consumption Market Share by Application in 2017
Figure Germany Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Germany Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure France Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure France Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure UK Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure UK Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure Italy Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Italy Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure Russia Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Russia Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure Spain Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Spain Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries in 2017
Table Middle East & Africa Human Rabies Immunoglobulin (IM) Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Human Rabies Immunoglobulin (IM) Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Human Rabies Immunoglobulin (IM) Value Market Share by Countries in 2017
Table Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption Market Share by Type in 2017
Table Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption Market Share by Application in 2017
Figure Egypt Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Egypt Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure South Africa Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure South Africa Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure Israel Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Israel Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure Turkey Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure Turkey Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Human Rabies Immunoglobulin (IM) Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Human Rabies Immunoglobulin (IM) Value Growth 2013-2018 ($ Millions)
Table Human Rabies Immunoglobulin (IM) Distributors List
Table Human Rabies Immunoglobulin (IM) Customer List
Figure Global Human Rabies Immunoglobulin (IM) Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Human Rabies Immunoglobulin (IM) Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Human Rabies Immunoglobulin (IM) Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Human Rabies Immunoglobulin (IM) Consumption Market Forecast by Regions
Table Global Human Rabies Immunoglobulin (IM) Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Human Rabies Immunoglobulin (IM) Value Market Share Forecast by Regions
Figure Americas Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Americas Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure APAC Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure APAC Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Europe Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Europe Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Middle East & Africa Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Middle East & Africa Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure United States Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure United States Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Canada Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Canada Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Mexico Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Mexico Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Brazil Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Brazil Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure China Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure China Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Japan Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Japan Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Korea Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Korea Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Southeast Asia Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Southeast Asia Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure India Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure India Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Australia Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Australia Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Germany Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Germany Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure France Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure France Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure UK Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure UK Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Italy Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Italy Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Russia Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Russia Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Spain Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Spain Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Egypt Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Egypt Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure South Africa Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure South Africa Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Israel Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Israel Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure Turkey Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure Turkey Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Figure GCC Countries Human Rabies Immunoglobulin (IM) Consumption 2018-2023 (K Units)
Figure GCC Countries Human Rabies Immunoglobulin (IM) Value 2018-2023 ($ Millions)
Table Global Human Rabies Immunoglobulin (IM) Consumption Forecast by Type (2018-2023) (K Units)
Table Global Human Rabies Immunoglobulin (IM) Consumption Market Share Forecast by Type (2018-2023)
Table Global Human Rabies Immunoglobulin (IM) Value Forecast by Type (2018-2023) ($ Millions)
Table Global Human Rabies Immunoglobulin (IM) Value Market Share Forecast by Type (2018-2023)
Table Global Human Rabies Immunoglobulin (IM) Consumption Forecast by Application (2018-2023) (K Units)
Table Global Human Rabies Immunoglobulin (IM) Consumption Market Share Forecast by Application (2018-2023)
Table Global Human Rabies Immunoglobulin (IM) Value Forecast by Application (2018-2023) ($ Millions)
Table Global Human Rabies Immunoglobulin (IM) Value Market Share Forecast by Application (2018-2023)
Table CSL Behring Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Behring Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure CSL Behring Human Rabies Immunoglobulin (IM) Market Share (2016-2018)
Table Grifols Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Grifols Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Grifols Human Rabies Immunoglobulin (IM) Market Share (2016-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Human Rabies Immunoglobulin (IM) Market Share (2016-2018)
Table Sichuan Yuanda Shuyang Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Market Share (2016-2018)
Table CNBG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CNBG Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure CNBG Human Rabies Immunoglobulin (IM) Market Share (2016-2018)
Table Kamada Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kamada Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Kamada Human Rabies Immunoglobulin (IM) Market Share (2016-2018)
Table CBPO Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CBPO Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure CBPO Human Rabies Immunoglobulin (IM) Market Share (2016-2018)
Table Shuanglin Bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Shuanglin Bio Human Rabies Immunoglobulin (IM) Market Share (2016-2018)
Table Weiguang Bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Weiguang Bio Human Rabies Immunoglobulin (IM) Market Share (2016-2018)
Table Shanghai RAAS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Shanghai RAAS Human Rabies Immunoglobulin (IM) Market Share (2016-2018)
Table Bharat Serum Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table VINS Basic Information, Manufacturing Base, Sales Area and Its Competitors